Full Text:

 

영남의대학술지 Vol.24_No.2 Suppl. P.S75-86, Dec. 2007

Review

국가 과학기술 정책의 종합조정체제와 생명공학 연구의 활성화*

Coordination and Activation of Biotechnology-Related R&D Budget of Korea

김정희
영남대학교 의과대학 생화학ㆍ분자생물학교실
책임저자:김정희, 대구광역시 남구 대명동 317-1, 영남대학교 의과대학 생화학?분자생물학교실
Tel: (053) 620-4341, Fax: (053) 654-6651
E-mail: jhykim@ynu.ac.kr

December 30, 2007

Abstract

Importance of science and technology is based on modern society which means knowledge based society. Now, today’s quality of science and technology in Korea says that is ordered as 8th powerful nationality in the world.
Research and development budget of our government is over KRW 9.8 trillion dollars in 2007, it is ordered amount of 8th national in the world. First nation is America, followed Japan, Germany, France, England, Italy, China. By the Swiss IMD report, it is evaluated as competitive power of science of our country is 7th order and technology is 6th order in the world. These show brilliant achievement by recent many research products.
In order to increase investment efficiency of research & development of government, reorganization of government setups were carried out national innovation system (NIS) in Oct. 2004. Policy of coordination and division of government R&D budget is in force strategy by selection and convergence, total roadmap in mid- and long-term by technological field.
The priority order by total roadmap take biological field as first. In the present 2007, government budget of biological field occupied 16.5%, it is developed 17% in next year. Next order is followed the Environment, the Space and the Universe. Strategy of R&D investment of fields of information and electron and field of machinery and the manufacturing industry will be decrease.
National R&D investment will be used as an advanced country form. It will be induced to increase a private enterprise. These field will be decrease a weight. Especially, a scientist for life have to effort to development of global new drug by Korea-America FTA (Free Trade Agreement) and we will see what we can do a sense of responsibility and good results.

*(전)과학기술부 과학기술혁신본부 생명해양심의관(2004~2006), 본문의 하부에는 지난 2년간 과학기술혁신 본부 출범 후의 우리나라 생명분야의 국가 R&D 정책 및 전략들의 일부를 소개하였다.

Key Words: R&D investment, Total roadmap

References

1. 한국경제연구원 KDI, 한국경제전망, 2002.

2. 삼성경제연구소 1월, 2004.

3. 미국과학재단(NSF), ‘03년 연구지원 통계, 2004.

4. 삼성경제연구소 1월, 2005; 미국: 과학진흥협회(AAAS), R&D FY 2003, 2004; 일본: 일본국립과학재단, 메모렌덤 2004; 문부과학성, 2002년도 과학기술관계경비 자료, 2월 2003; 독일: 연방교육연구부(BMBF), Bundesdeutsche Forschung 2002, 2003; 영국: 무역산업부(DTI), The Forward Look 2001, 2002.

5. 과학기술부, 제10차 5개년 과학기술기본계획(’01 ~’05), 2000.

6. 한국경제연구원 KDI, 2006년의 IMD 보고서, 2007.

7. 한국경제연구원 KDI, 한국경제전망, 2007.

8. 과학기술부, 제 1차 생명공학육성 기본계획, 12월, 1993.

9. 과학기술부, 제 2차 생명공학육성 기본계획, 12월, 2006.

10. 과학기술부, 2005년 주요 과학기술통계, 2006.

11. 과학기술부, 바이오분야 R&D 최근동향. 생명해양심의관실, 2006

12. 과학기술부, 제 12회 과학기술관계장관회의 제 4호 안건, 바이오 연구 개발의 효율적 추진전략. 11월, 2005.